Fulvedex 250mg/5ml Injection is an advanced clinical therapy for hormone-receptor-positive breast cancer, available via PakMeds for specialized home delivery.

Fulvedex 250mg/5ml Inj. Ingredients and Usage

Fulvedex Injection contains Fulvestrant, a selective estrogen receptor degrader (SERD). It is clinically utilized for the treatment of hormone-receptor-positive, HER2-negative advanced breast cancer in postmenopausal women. It is also used in combination with other agents like palbociclib for certain types of metastatic breast cancer. PakMeds ensures that this critical oncology medication is handled with the utmost care and delivered promptly to support patients undergoing advanced cancer treatment.

How Does Fulvedex 250mg/5ml Inj. Work?

Fulvestrant works by binding to the estrogen receptors in breast cancer cells and blocking the action of estrogen. Unlike traditional hormone therapies that only block the receptor, Fulvestrant also causes the down-regulation and degradation of the estrogen receptor protein itself. Since many breast cancers rely on estrogen to grow, this dual action effectively starves the tumor cells of the growth signals they need, thereby slowing or stopping the progression of the disease.

Fulvedex 250mg/5ml Inj. Side Effects

Common side effects include injection site reactions (pain or inflammation), nausea, and bone pain. Patients may also experience hot flashes, headache, and elevated liver enzymes. Less common but serious effects include thromboembolic events or severe hypersensitivity reactions.

List of Warnings:

• Must be administered only by a healthcare professional via slow intramuscular injection.
• Use with caution in patients with bleeding diatheses or those on anticoagulants.
• Not recommended for use in patients with severe hepatic impairment.
• Females of reproductive potential should use effective contraception during treatment.

Fulvedex 250mg/5ml Inj. Storage Conditions

Fulvedex must be stored in a refrigerator at 2°C to 8°C. Do not freeze. Keep the pre-filled syringe in its original carton to protect it from light. Prior to administration, it may be allowed to reach room temperature for patient comfort.